A recent and alarming case of Middle East Respiratory Syndrome Coronavirus (Mers-CoV) has been identified in Abu Dhabi’s Al Ain, as reported by the World Health Organisation (WHO). The patient, a 28-year-old expat, tested positive following a PCR test conducted in June. The WHO has expressed deep concern over this development and is closely monitoring the situation.
Also read: Abu Dhabi: A List Of All The Sports Shows, Events & Concerts To Expect This August
Thorough Contact Tracing And No Secondary Cases
In response to the detection of the Mers-CoV case, the UN health agency took immediate action and meticulously tracked down all 108 individuals who had come into contact with the infected patient. These contacts were closely monitored for two weeks from their last exposure to the patient. Encouragingly, no secondary cases were detected during this surveillance period. However, despite this fortunate outcome, the WHO continues to remain vigilant and urges further precautions.
Rare Incidence Of Mers-CoV In The UAE
Mers-CoV infections are fortunately rare in the United Arab Emirates (UAE). Since July 2013, including the recent case, a total of 94 cases and 12 deaths have been reported in the country. The rarity of these cases, though reassuring, underscores the importance of prompt and robust action to prevent any potential outbreaks.
Efforts To Strengthen Surveillance And Raise Awareness
The WHO has highlighted the crucial efforts undertaken by the Abu Dhabi Public Health Centre (ADPHC) in enhancing surveillance activities. The ADPHC has been diligently working to identify possible cases and has conducted several workshops to raise awareness about Mers-CoV among the public and healthcare professionals. However, with the emergence of this recent case, there is an urgent need for everyone to be well-informed about this viral disease and the measures to protect themselves.
Understanding Mers-CoV: Symptoms & Precautions
Mers Virus: A Potentially Lethal Infection
Middle East Respiratory Syndrome (Mers) is caused by a coronavirus known as Middle East Respiratory Syndrome Coronavirus (Mers-CoV). This viral respiratory infection affects both humans and dromedary camels and has a high mortality rate. According to the WHO, approximately 35 per cent of infected patients do not survive, making it a matter of utmost concern.
Routes of Transmission: Zoonotic Nature And Human-to-Human Spread
Mers-CoV is a zoonotic virus, meaning it can be transmitted from animals to humans. The WHO states that individuals can become infected through direct or indirect contact with infected dromedary camels. However, the exact mode of transmission remains unclear, as evident from the latest case in Al Ain, where the patient had no history of contact with camels or other potential sources of infection. Moreover, human-to-human transmission is also possible, particularly among close contacts and in healthcare settings.
Symptoms Of Mers-CoV
- Typical symptoms of MERS include fever, cough, and shortness of breath. While pneumonia is common, not all patients develop this condition. Some may also experience gastrointestinal symptoms like diarrhea.
- Approximately 35% of MERS cases reported to the World Health Organization (WHO) have resulted in death, making it a highly concerning respiratory infection.
- MERS-CoV is a zoonotic virus, meaning it can be transmitted between animals and humans. Dromedary camels in regions like the Middle East, Africa, and South Asia have been linked to MERS infections.
- Transmission of MERS can occur through direct contact with infected camels or through human-to-human transmission. Close contacts and healthcare settings are the primary areas for human-to-human spread.
- Healthcare facilities have experienced the largest outbreaks of MERS, highlighting the importance of infection control measures in such environments.
Remember, staying informed about MERS and adopting preventive measures are crucial to safeguarding public health and preventing further spread.
Risk Factors
Individuals with weakened immune systems, chronic diseases, and older age groups seem to be at greater risk of developing severe disease and complications.
Limited Treatment Options: Focus On Prevention
As of now, there is no specific vaccine or treatment available for Mers-CoV. Supportive care based on the patient’s clinical condition is the current approach. However, the WHO is actively supporting the development of Mers-CoV-specific vaccines and treatments through clinical trials. Nevertheless, the best course of action remains focused on prevention.
Urgent Precautions And Hygiene Measures
The WHO emphasises that individuals visiting places where dromedary camels and other animals are present should adhere to general hygiene measures, including regular handwashing before and after contact with animals. Caution should be exercised to avoid contact with sick animals. Additionally, consuming raw or undercooked animal products, including milk and meat, carries a high risk of infection from various pathogens that can cause disease in humans. Hence, appropriate cooking or pasteurisation of animal products is vital to minimise the risk.
Immediate Genomic Analysis
In response to the unusual presentation of the latest case in Al Ain, the WHO has initiated genomic analysis to better understand the genetic evolution of the virus. This analysis will aid in screening for any atypical patterns and support the WHO’s global risk assessment efforts. It is essential to gather comprehensive data to combat the potential spread of Mers-CoV effectively.
Given the gravity of this situation, it is of utmost importance that individuals and authorities alike act swiftly and responsibly to prevent further transmission of Mers-CoV. Stay informed, practice necessary precautions, and work together to protect public health and well-being. The WHO remains committed to providing continuous updates and support in the battle against this infectious threat.
You may also like: What To Expect This August In Dubai: Concerts, Events, And Exciting Activities To Enjoy
